glutathione withdrawal Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Cancer cells are sensitive to

GLOW Peptide Regulatory Status As of June 2026, none of the three GLOW compounds (BPC-157, TB-500, GHK-Cu) are FDA-approved for injectable human use

Myers Cocktail IV therapy is ideal for individuals experiencing fatigue, stress, low energy, or frequent illness, as well as those looking for a comprehensive wellness boost

Anti-inflammatory effects of four psilocybin-containing magic mushroom water extracts in vitro on 15-lipoxygenase activity and on lipopolysaccharide-induced cyclooxygenase-2 and inflammatory cytokines in human U937 macrophage cells

NAD through IV is proven to give you a faster, more effective outcome